Does PATISIRAN Cause Poor venous access? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Poor venous access have been filed in association with PATISIRAN (Onpattro). This represents 0.6% of all adverse event reports for PATISIRAN.
15
Reports of Poor venous access with PATISIRAN
0.6%
of all PATISIRAN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Poor venous access From PATISIRAN?
Of the 15 reports, 4 (26.7%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Product dose omission issue (175)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which PATISIRAN Alternatives Have Lower Poor venous access Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A